Pharmaron Beijing Co LtdEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 22.58 HKD | 29,783 HKD | 14,289 HKD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - HKD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 359.977.887 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Pharmaron Beijing Co Ltd
Mitarbeiter 25.088
Handelsplatz HK
Ticker Symbol 3759
IPO Datum -
Adresse Building 1, Beijing, China, 100176
Webseite https://www.pharmaron.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Boliang Lou Ph.D. | Chairman & CEO |
| 2 | Mr. Xiaoqiang Lou EMBA | Co-Founder, President, COO & Executive Director |
| 3 | Mr. Shing Chung Li C.F.A., CPA | CFO, Secretary of the Board, Accounting Supervisor & Employee Representative Director |
| 4 | Dr. Hua Yang Ph.D. | Chief Scientific Officer & Deputy Manager |
| 5 | Ms. Bei Zheng M.A. | Executive VP & Executive Director |
| 6 | Dr. Connie Sun Ph.D. | Senior VP & Global Head of Business Development of Small Molecules |
| 7 | Ms. Celina Zhong M.B.A. | Senior Vice President of Human Resources |
| 8 | Ms. Katherine Lee M.B.A. | Chief Business Officer |
| 9 | Mr. Stephen Lewinton | Senior Vice President of UK Operations |
| 10 | Dr. Jingqi Huang | Senior Vice President of In Vivo Pharmacology |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.